Skip to main content
An official website of the United States government

Funded Grants

Grants awarded in the current fiscal year and carried over from prior fiscal years.

PI Name PI Organization Title Grant Number Sort descending Program Official
Atigadda, Venkatram Reddy

University Of Alabama At Birmingham
United States

Development of Potent and non-toxic rexinoids to prevent non-melanoma skin cancer 5R01CA276683-03
Hilakivi-Clarke, Leena A.

University Of Minnesota
United States

Effect of maternal obesity on breast cancer among offspring: role of the gut microbiota 5R01CA276775-03 Amit Kumar, Ph.D.
Huang, Ying

Fred Hutchinson Cancer Center
United States

Accelerating biomarker development through novel statistical methods for analyzing phase III/IV studies 5R01CA277133-04 Matthew Young, Ph.D.
Zhu, Yazhen

University Of California Los Angeles
United States

Click Chemistry-Mediated Surface Protein Assay for Quantifying Subpopulations of Hepatocellular Carcinoma-associated Extracellular Vesicles 5R01CA277530-03 Matthew Young, Ph.D.
Rosser, Charles J

Cedars-Sinai Medical Center
United States

A Multiplex Protein Biomarker-Based Immunoassay for the Early Detection of Bladder Cancer and its Implications in Tumor Biology 5R01CA277810-03 Guillermo Marquez, Ph.D.
Yaghjyan, Lusine

University Of Florida
United States

Stromal contributions to breast carcinogenesis 5R01CA277817-03 Christos Patriotis, Ph.D., M.Sc.
Mehrara, Babak J

Sloan-Kettering Inst Can Research
United States

Mechanisms of racial disparity in breast cancer-related lymphedema 5R01CA278599-04 Asad Umar, D.V.M., Ph.D.
Jacob, Jennifer B

Henry Ford Health + Michigan State University Health Sciences
United States

Defining Cancer Intervention Targets by Functional Genomics Analysis of Outbred F1 Mice 5R01CA278818-03 Anda Vlad, M.D., Ph.D.
Garcia, Jose M.

Seattle Inst For Biomedical/Clinical Res
United States

SArcopenia in Men with Prostate Cancer undergoing ADT (SAP-ADT) 5R01CA279220-03 Marjorie Perloff, M.D.
Bartolini, Francesca

Columbia University Health Sciences
United States

Investigating the Pathogenic Role of Tubulin Post-translational Modifications in CIPN 5R01CA279401-02 Rachel Altshuler, Ph.D.